IRIS

1.1 Articolo in rivista: [26879] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 7.741 a 7.760 di 26.879
Titolo Data di pubblicazione Autore(i) File
Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials 1-gen-2010 Lorusso, D; Mainenti, S.; Ferrandina, G.; Scambia, G.
Phase II study of oxaliplatin (OXA) and docetaxel (DTX) in recurrent ovarian cancer 1-gen-2006 Ferrandina, G.; Ludovisi, M.; D'Agostino, G.; Naldini, A.; Lorusso, D; Testa, A. C.; Legge, F.; Salutari, V.; Scambia, G.
Concentrate-related inhibitor risk : is a difference always real? 1-gen-2011 Iorio, A.; Marcucci, M.; Makris, M.
Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards : the REPOSI study 1-gen-2011 Nobili, A.; Licata, G.; Salerno, F.; Pasina, L.; Tettamanti, M.; Franchi, C.; De Vittorio, L.; Marengoni, A.; Corrao, S.; Iorio, A.; Marcucci, M.; Mannucci, P. M.
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in very platinum-sensitive ovarian cancer patients: Results from a subset analysis of the CALYPSO phase III trial 1-gen-2015 Mahner, S; Meier, W; du Bois, A; Brown, C; Lorusso, D; Dell'Anna, T; Cretin, J; Havsteen, H; Bessette, P; Zeimet, Ag; Vergote, I; Vasey, P; Pujade-Lauraine, E; Gladieff, L; Ferrero, A
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial 1-gen-2012 Gladieff, L.; Ferrero, A.; De Rauglaudre, G.; Brown, C.; Vasey, P.; Reinthaller, A.; Pujade-Lauraine, E.; Reed, N.; Lorusso, D; Siena, S.; Helland, H.; Elit, L.; Mahner, S.
Individual participant data meta-analyses compared with meta-analyses based on aggregate data 1-gen-2016 Tudur Smith, C.; Marcucci, M.; Nolan, S. J.; Iorio, A.; Sudell, M.; Riley, R.; Rovers, M. M.; Williamson, P. R.
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study 1-gen-2021 Daniele, G; Raspagliesi, F; Scambia, G; Pisano, C; Colombo, N; Frezzini, S; Tognon, G; Artioli, G; Gadducci, A; Lauria, R; Ferrero, A; Cinieri, S; De Censi, A; Breda, E; Scollo, P; De Giorgi, U; Lissoni, Aa; Katsaros, D; Lorusso, D; Salutari, V; Cecere, Sc; Zaccarelli, E; Nardin, M; Bogani, G; Distefano, M; Greggi, S; Piccirillo, Mc; Fossati, R; Giannone, G; Arenare, L; Gallo, C; Perrone, F; Pignata, S
Perioperative management of antiplatelet therapy in patients with a coronary stent who need noncardiac surgery : a systematic review of clinical practice guidelines 1-gen-2013 Darvish Kazem, S.; Gandhi, M.; Marcucci, M.; Douketis, J. D.
Prevalence of potentially inappropriate medications and risk of adverse clinical outcome in a cohort of hospitalized elderly patients : results from the REPOSI Study 1-gen-2014 Pasina, L.; Djade, C. D.; Tettamanti, M.; Franchi, C.; Salerno, F.; Corrao, S.; Marengoni, A.; Marcucci, M.; Mannucci, P. M.; Nobili, A.
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: A prospective, longitudinal study 1-gen-2012 Ferrandina, Gabriella; Mantegna, Giovanna; Petrillo, Marco; Fuoco, Gilda; Venditti, Laura; Terzano, Serena; Moruzzi, Cristina; Lorusso, D; Marcellusi, Andrea; Scambia, Giovanni
Gemcitabine in epithelial ovarian cancer treatment: current role and future perspectives 1-gen-2005 Lorusso, D; Ferrandina, G; Fruscella, E; Marini, L; Adamo, V; Scambia, G
Trabectedin as single agent in the salvage treatment of heavily treated ovarian cancer patients: A retrospective, multicenter study 1-gen-2013 Ferrandina, G; Salutari, V; Vincenzi, B; Marinaccio, M; Naglieri, E; Loizzi, V; Carpano, S; Amadio, G; Tonini, G; Scambia, G; Lorusso, D
Adverse clinical events and mortality during hospitalization and 3 months after discharge in cognitively impaired elderly patients 1-gen-2013 Marengoni, A.; Nobili, A.; Romano, V.; Tettamanti, M.; Pasina, L.; Djade, S.; Corrao, S.; Salerno, F.; Iorio, A.; Marcucci, M.; Mannucci, P. M.
Short-course olanzapine to prevent delayed emesis following carboplatin/paclitaxel for gynecologic cancer: a randomised study 1-gen-2019 20., Celio L; Saibene, G; Lepori, S; Festinese, F; Niger, M; Raspagliesi, F; Lorusso, D
Survival with Cemiplimab in Recurrent Cervical Cancer 1-gen-2022 Tewari, Ks; Monk, Bj; Vergote, I; Miller, A; de Melo, Ac; Kim, Hee-S; Kim Yong, M; Lisyanskaya, A; Samouëlian, Va; Lorusso, D; Damian, F; Chang, Cl; Gotovkin, Ea; Takahashi, S; Ramone, D; Pikiel, J; Maćkowiak-Matejczyk, B; Guerra Alía, Em; Colombo, N; Makarova, Y; Rischin, D; Lheureux, S; Hasegawa, K; Fujiwara, K; Li, J; Jamil, S; Jankovic, V; Chen, Ci; Seebach, F; Weinreich, Dm; Yancopoulos, Gd; Lowy, I; Mathias, M; Fury, Mg; Oaknin, A
Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial 1-gen-2021 Pignata, S; Lorusso, D; Joly, F; Gallo, C; Colombo, N; Sessa, C; Bamias, A; Salutari, V; Selle, F; Frezzini, S; De Giorgi, U; Pautier, P; Bologna, A; Orditura, M; Dubot, C; Gadducci, A; Mammoliti, S; Ray-Coquard, I; Zafarana, E; Breda, E; Favier, L; Ardizzoia, A; Cinieri, S; Largillier, R; Sambataro, ; Guardiola, E; Lauria, R; Pisano, C; Raspagliesi, F; Scambia, G; Daniele, G; Perrone, F
Type and intensity of FVIII exposure on inhibitor development in PUPs with haemophilia A : a patient-level meta-analysis 1-gen-2015 Marcucci, M.; Mancuso, M.; Santagostino, E.; Kenet, G.; Elalfy, M.; Holzhauer, S.; Bidlingmaier, C.; Escuriola Ettingshausen, C.; Iorio, A.; Nowak Göttl, U.
Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancer 1-gen-2021 Vergote, I; Ray-Coquard, I; Anderson, Dm; Cantuaria, G; Colombo, N; Garnier-Tixidre, C; Gilbert, L; Harter, P; Hettle, R; Lorusso, D; Mäenpää, J; Marth, C; Matsumoto, K; Ouwens, M; Poveda, A; Raspagliesi, F; Rhodes, K; Rubio Pérez, Mj; Shapira-Frommer, R; Shikama, A; Sikorska, M; Moore, K; Disilvestro, P
Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or B 1-gen-2014 Athale, A. H.; Marcucci, M.; Iorio, A.
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 7.741 a 7.760 di 26.879
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista26879
Autore
  • OYEN, Willem Jozef Gerard891
  • SANTORO, Armando806
  • CANONICA, Giorgio775
  • REPICI, Alessandro723
  • HASSAN, CESARE690
  • DANESE, Silvio643
  • FASANO, ALFONSO471
  • Marcacci, Maurilio467
  • D'INCALCI, MAURIZIO466
  • LAGHI, ANDREA456
Data di pubblicazione
  • In corso di stampa6
  • 2020 - 20269083
  • 2010 - 201911532
  • 2000 - 20094500
  • 1990 - 19991429
  • 1980 - 1989306
  • 1975 - 197923
Editore
  • Edition AERCV1
  • Elsevier1
  • Futura Publishing Company1
  • Grafica Luigi Monti s.r.l.1
  • Karger, Basel1
  • Mosby1
  • sn1
  • Springer-Verlag1
  • Thieme1
Rivista
  • DIGESTIVE AND LIVER DISEASE368
  • EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
  • ANNALS OF ONCOLOGY243
  • CANCERS227
  • THE JOURNAL OF NUCLEAR MEDICINE220
  • PLOS ONE212
  • EUROPEAN JOURNAL OF CANCER205
  • GASTROINTESTINAL ENDOSCOPY193
  • JOURNAL OF CLINICAL MEDICINE182
  • ALLERGY180
Keyword
  • Humans2101
  • Female1005
  • Male964
  • Middle Aged745
  • Aged643
  • Adult550
  • COVID-19415
  • Treatment Outcome359
  • Animals321
  • Retrospective Studies262
Lingua
  • eng19160
  • ita408
  • spa13
  • fre11
  • ger8
  • enm3
  • por2
  • chi1
Accesso al fulltext
  • no fulltext24626
  • reserved1362
  • open891